- Home
- LIXT vs RMCF Comparison
LIXT vs RMCF Comparison
Compare LIXT & RMCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- RMCF
- Stock Information
- Founded
- LIXT 2005
- RMCF 1981
- Country
- LIXT United States
- RMCF United States
- Employees
- LIXT N/A
- RMCF N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- RMCF Specialty Foods
- Sector
- LIXT Health Care
- RMCF Consumer Staples
- Exchange
- LIXT Nasdaq
- RMCF Nasdaq
- Market Cap
- LIXT 12.4M
- RMCF 11.6M
- IPO Year
- LIXT N/A
- RMCF N/A
- Fundamental
- Price
- LIXT $4.85
- RMCF $1.52
- Analyst Decision
- LIXT
- RMCF
- Analyst Count
- LIXT 0
- RMCF 0
- Target Price
- LIXT N/A
- RMCF N/A
- AVG Volume (30 Days)
- LIXT 193.9K
- RMCF 39.8K
- Earning Date
- LIXT 08-07-2025
- RMCF 07-15-2025
- Dividend Yield
- LIXT N/A
- RMCF N/A
- EPS Growth
- LIXT N/A
- RMCF N/A
- EPS
- LIXT N/A
- RMCF N/A
- Revenue
- LIXT N/A
- RMCF $29,545,000.00
- Revenue This Year
- LIXT N/A
- RMCF N/A
- Revenue Next Year
- LIXT N/A
- RMCF N/A
- P/E Ratio
- LIXT N/A
- RMCF N/A
- Revenue Growth
- LIXT N/A
- RMCF 5.81
- 52 Week Low
- LIXT $0.64
- RMCF $1.12
- 52 Week High
- LIXT $5.14
- RMCF $3.49
- Technical
- Relative Strength Index (RSI)
- LIXT 64.92
- RMCF 41.25
- Support Level
- LIXT $4.20
- RMCF $1.41
- Resistance Level
- LIXT $5.06
- RMCF $1.66
- Average True Range (ATR)
- LIXT 0.44
- RMCF 0.11
- MACD
- LIXT -0.02
- RMCF -0.04
- Stochastic Oscillator
- LIXT 80.79
- RMCF 20.00
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.